TIA: Clinical Trials

5 trials for TIA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 active not recruiting, 1 terminated, 1 unknown. 5 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 45Completed 2, Active not recruiting 1, Terminated 1, Unknown 1

Follow TIA: new trials by email Literature Review of TIA trials Research Report on TIA

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cilostazol and Aspirin in Stroke and TIA
Cilostazol, Clopidogrel - Ischemic Stroke, TIA
Phase 4CompletedIncheon St.Mary's Hospital3782019-07-182024-08-06
Early Rivaroxaban for Acute Ischemic Stroke or TIA Patients With Atrial Fibrillation
Rivaroxaban - Cerebral Infarction, TIA
Phase 4CompletedGeneral Hospital of Shenyang Military Region4002018-11-202025-08-21
Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure
Rivaroxaban, dabigatran, apixaban, or edoxaban, Clopidogrel -75 mg/day, Low dose aspirin -80 to 125 mg/day- - Left Atrial Appendage Closure, Thrombosis
Phase 4Active not recruitingCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec5102018-09-012026-03-27
Relation of Carotid Artery Plaque Inflammation, Covert Stroke and White Matter Disease
PET/CT imaging with F-18 fluorodeoxyglucose - TIA, Stroke
Phase 4TerminatedOttawa Heart Institute Research Corporation502010-11-012017-04-24
Sleep Disordered Breathing in Transient Ischemic Attack (TIA)/Ischemic Stroke and Continuous Positive Airway Pressure (CPAP) Treatment Efficacy
CPAP - TIA, Ischemic Stroke
Phase 4UnknownProf. Claudio Bassetti2462010-07-012015-10-26

Narrower conditions

Ischemic Stroke (2)  ·  Stroke (2)  ·  Carotid Stenosis (1)  ·  Cerebral Infarction (1)  ·  Hemorrhage (1)  ·  Sleep Apnea Syndromes (1)  ·  Thrombosis (1)

Broader conditions

Brain Diseases (5)  ·  Cardiovascular Diseases (5)  ·  Central Nervous System Diseases (5)  ·  Cerebrovascular Disorders (5)  ·  Nervous System Diseases (5)  ·  Vascular Diseases (5)  ·  Stroke (3)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Apnea (1)  ·  Arterial Occlusive Diseases (1)  ·  Brain Infarction (1)  ·  Brain Ischemia (1)  ·  Carotid Artery Diseases (1)  ·  Dyssomnias (1)

Interventions

Rivaroxaban (2)  ·  Aspirin (1)  ·  Cilostazol (1)  ·  Clopidogrel (1)  ·  Dabigatran (1)  ·  Fluorodeoxyglucose F18 (1)  ·  apixaban (1)  ·  edoxaban (1)

Sponsors

Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec (1)  ·  General Hospital of Shenyang Military Region (1)  ·  Incheon St.Mary's Hospital (1)  ·  Ottawa Heart Institute Research Corporation (1)  ·  Prof. Claudio Bassetti (1)

Countries

Canada (2)  ·  China (1)  ·  Germany (1)  ·  Italy (1)  ·  South Korea (1)  ·  Switzerland (1)

Top investigators

Carlo Cereda, Capo CLinica (1)  ·  Claudio Bassetti, Professor (1)  ·  Huisheng Chen, Doctor (1)  ·  Lino Nobili, Prof. MD (1)  ·  Mauro Manconi, MD (1)  ·  Peter Young, Prof. MD (1)  ·  Sebastian Ott, MD (1)  ·  Taewon Kim, Dr (1)  ·  Terrence Ruddy, MD (1)

Results publications

PMID 20665856, PMID 20723861, PMID 22812731, PMID 24435018, PMID 24682348, PMID 25060026, PMID 25604089, PMID 25777666, PMID 26993976, PMID 27765196, PMID 27931603, PMID 28065447, PMID 28145040, PMID 28231907, PMID 28495432, PMID 29146668, PMID 29183961, PMID 29622159, PMID 30032306, PMID 41139402